SAN RAFAEL, Calif.,
April 22, 2020 /PRNewswire/
-- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced
that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of
BioMarin, will host a conference call and webcast on Wednesday, April 29, at 4:15 p.m. ET to discuss first quarter 2020
financial results and provide a general business update. The timing
of the call has been modified to increase the ability of our
investors and analysts to participate.
Dial-in Number
U.S. / Canada Dial-in Number: (833) 360-0852
International Dial-in Number: (630) 652-5841
Conference ID: 6194595
Replay Dial-in Number: (855) 859-2056
Replay International Dial-in Number: (404) 537-3406
Conference ID: 6194595
Interested parties may access a live audio webcast of the
conference call via the investor section of the BioMarin
website, www.biomarin.com. A replay of the call will be
archived on the site for one week following the call.
About BioMarin
BioMarin is a global biotechnology
company that develops and commercializes innovative therapies for
patients with serious and life-threatening rare genetic diseases.
The company's portfolio consists of six commercialized products and
multiple clinical and pre-clinical product candidates. For
additional information, please visit www.biomarin.com. Information
on BioMarin's website is not incorporated by reference into this
press release.
|
Contacts:
|
|
|
Investors
|
Media
|
|
Traci
McCarty
|
Debra
Charlesworth
|
|
BioMarin
Pharmaceutical Inc.
|
BioMarin
Pharmaceutical Inc.
|
|
(415)
455-7558
|
(415)
455-7451
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/biomarin-updates-timing-of-first-quarter-2020-financial-results-conference-call-and-webcast-to-wednesday-april-29-at-415pm-et-301044737.html
SOURCE BioMarin Pharmaceutical Inc.